Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD Patients
Clinical trial NCT04290429 · COMPLETED
Trial details
- NCT number
- NCT04290429
- Sponsor
- University of Freiburg
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-06
- Primary completion
- 2019-12-06
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.